Maintaining mask momentum in transplant recipients

The widespread use of facemasks has been a crucial element in the control of the SARS-CoV-2 pandemic. With mounting evidence for mask efficacy against respiratory infectious diseases and greater acceptability of this intervention, it is proposed that masking should continue after the pandemic has abated to protect some of our most vulnerable patients, recipients of stem cell and solid organ transplants. This may involve not only masking these high-risk patients, but possibly their close contacts and the healthcare workers involved in their care. We review the evidence for mask efficacy in prevention of respiratory viruses other than SARS-CoV-2 and address the burden of disease in transplant recipients. Although we acknowledge that there are limited data on masking to prevent infection in transplant recipients, we propose a framework for the study and implementation of routine masking as a part of infection prevention interventions after transplantation.

Automated summary

The widespread use of facemasks has been crucial in controlling the SARS-CoV-2 pandemic, and it is suggested that continued masking after the pandemic can help protect vulnerable transplant recipients. Limited data on masking for infection prevention in transplant recipients highlights the need for further study and implementation of routine masking post-transplantation.